Skip to main content

Table 3 Clinical characteristics of patients who underwent genome biopsy with EBUS-TBNA

From: Utility of needle biopsy in centrally located lung cancer for genome analysis: a retrospective cohort study

 

EBUS-TBNA patients (n = 134)

(%)

Re-biopsy patients (n = 9)

(%)

Age-median, [range]

Median

68 [30–89]

 

69 [35–73]

 

Sex-no. (%)

Male

101

(75.4)

8

(41.6)

Female

33

(24.6)

1

(58.4)

Histology-no. (%)

Ad

78

(58.2)

5

(58.4)

Sq

28

(20.9)

2

(20.8)

NSCLC

28

(20.9)

2

(20.8)

Stage-n. (%)

IVA, B

83

(61.9)

5

(55.6)

IIIA,B,C

51

(38.1)

4

(44.4)

Tumor location

#2

3

(2.2)

0

 

#4

60

(44.8)

2

(22.2)

#7

40

(29.9)

3

(33.4)

#10

4

(3.0)

1

(11.1)

#11

9

(6.7)

0

 

#12

5

(3.7)

0

 

Upper lobe

4

(3.0)

1

(11.1)

Lower lobe

8

(6.0)

2

(22.2)

Other

1

(0.7)

0

 

ROSE

Positive

  

8

(88.9)

  1. EBUS-TBNA Endobronchial ultrasound-guided transbronchial needle aspiration, ROSE rapid-onsite evaluation